Single dose of two PrEP tablets in healthy volunteers
Part of Infections clinical trials.
This study tests how taking two tablets of a PrEP medication (F/TAF) at once affects healthy volunteers. It helps us understand the safety and how the body processes the drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You are in good general health
- You tested negative for HIV in the last 4 weeks
- Your kidneys work well (estimated filtration rate of 70 mL/min or higher)
- You agree to use condoms during sex for the study
- You have not used oral PrEP pills in the last 2 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people who got exposed to HIV despite taking the long-acting PrEP shot (cabotegravir). It tests different pill-based HIV treatment plans to find the best option for them.
This trial checks how well PrEP pills (TDF/FTC) prevent HIV in people who are at high risk and are HIV-negative. It may help you understand whether PrEP is a good prevention option for your situation.
This study tests a new approach to help young gay and bisexual men who take PrEP medication prevent HIV but sometimes miss doses or have condomless sex. It aims to see if behavioral strategies can improve adherence to PrEP and reduce risky behaviors.
This study is testing a decision-support tool that helps emergency department patients learn about and start taking PrEP, a daily medicine that prevents HIV. If you are HIV negative and visiting the ER for a non-life-threatening issue, this study may help you access HIV prevention.
This study follows adults who are at high risk of getting HIV while they take HIV prevention pills (PrEP). It aims to learn how well PrEP fits real-life use in people at risk and who may need extra care.
This trial tests a new way to take HIV prevention medicine (PrEP) only around the time you have sex, using a pill called TAF/FTC. It aims to see if this 'on-demand' method is effective, safe, and acceptable, and could offer a more flexible option than taking a pill every day.
Hear when a new HIV Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.